Literature DB >> 11358901

Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence.

F Citarda1, G Tomaselli, R Capocaccia, S Barcherini, M Crespi.   

Abstract

BACKGROUND: Colorectal cancer is one of the leading causes of death from cancer in Western countries. Removal of adenomas is based on the assumption that it could lead to a reduction in the incidence of colorectal cancer, as demonstrated by the National Polyp Study in the USA. A critical issue is whether the benefit observed in clinical trials can also be observed in standard clinical practice. To address the issue, a multicentre Italian collaborative study was organised.
METHODS: The study cohort comprised 1693 subjects of both sexes, aged 40-69 years, enrolled between 1980 and 1987 following a total colon examination (TCE) (that is, total colonoscopy or colonoscopy and double contrast barium enema), with removal of at least one adenoma larger than 5 mm in diameter. Exclusion criteria were genetic syndromes, previous adenomas or colorectal cancer, previous colonic resection, inflammatory bowel disease, or sessile adenomas more than 3 cm in diameter. Follow up ended in December 1996 by TCE or telephone interview, and review of the medical records, clinical files, or death certificates. Incidence ratios for colorectal cancer were compared with expected age and sex specific incidences in the Italian general population.
RESULTS: Follow up data were obtained for 97.3% of cases for a total of 14 211 person/years. Mean follow up was 10.5 years. Six colorectal cancer cases (four in males, two in females) at various stages were ascertained (one at 29 months, two at five years, one at seven years, one at eight years, and one at 10 years from the index examination). The number of cancers expected in the reference population was 17.7 for an incidence ratio of 0.34 (confidence interval 0.23-0.63; p<0.01).
CONCLUSIONS: Colonoscopic polypectomy substantially reduced the incidence of colorectal cancer in the cohort compared with that expected in the general population. These results are of particular relevance considering that those with adenomas are at increased risk of colorectal cancer and that this retrospective study was performed on data obtained in standard clinical practice. This observation strengthens the concept of effective population screening in view of the fact that adenomatous polyps are the most frequent neoplastic outcome of screening and their removal is associated with a decrease in the incidence of colorectal cancer.

Entities:  

Mesh:

Year:  2001        PMID: 11358901      PMCID: PMC1728339          DOI: 10.1136/gut.48.6.812

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  19 in total

1.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.

Authors:  J D Hardcastle; J O Chamberlain; M H Robinson; S M Moss; S S Amar; T W Balfour; P D James; C M Mangham
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

2.  Randomised study of screening for colorectal cancer with faecal-occult-blood test.

Authors:  O Kronborg; C Fenger; J Olsen; O D Jørgensen; O Søndergaard
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

3.  Estimating relative survival of Italian cancer patients from sparse cancer registries data.

Authors:  R De Angelis; R Capocaccia; A Verdecchia
Journal:  Tumori       Date:  1997 Jan-Feb

4.  Estimation and projections of colorectal cancer trends in Italy.

Authors:  R Capocaccia; R De Angelis; L Frova; G Gatta; M Sant; A Micheli; F Berrino; E Conti; L Gafà; L Roncucci; A Verdecchia
Journal:  Int J Epidemiol       Date:  1997-10       Impact factor: 7.196

5.  Screening sigmoidoscopy and colorectal cancer mortality.

Authors:  P A Newcomb; R G Norfleet; B E Storer; T S Surawicz; P M Marcus
Journal:  J Natl Cancer Inst       Date:  1992-10-21       Impact factor: 13.506

6.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.

Authors:  J S Mandel; J H Bond; T R Church; D C Snover; G M Bradley; L M Schuman; F Ederer
Journal:  N Engl J Med       Date:  1993-05-13       Impact factor: 91.245

7.  Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy.

Authors:  S J Winawer; B J Flehinger; D Schottenfeld; D G Miller
Journal:  J Natl Cancer Inst       Date:  1993-08-18       Impact factor: 13.506

8.  Long-term risk of colorectal cancer after excision of rectosigmoid adenomas.

Authors:  W S Atkin; B C Morson; J Cuzick
Journal:  N Engl J Med       Date:  1992-03-05       Impact factor: 91.245

9.  A case-control study of screening sigmoidoscopy and mortality from colorectal cancer.

Authors:  J V Selby; G D Friedman; C P Quesenberry; N S Weiss
Journal:  N Engl J Med       Date:  1992-03-05       Impact factor: 91.245

10.  Trends of colorectal cancer incidence and prevalence in Italian regions.

Authors:  R De Angelis; F Valente; L Frova; A Verdecchia; G Gatta; E Chessa; F Berrino
Journal:  Tumori       Date:  1998 Jan-Feb
View more
  163 in total

1.  Factors associated with adherence to the recommended postpolypectomy surveillance interval.

Authors:  Eun Ran Kim; Dong Hyun Sinn; Jin Yong Kim; Dong Kyung Chang; Poong-Lyul Rhee; Jae J Kim; Jong Chul Rhee; Young-Ho Kim
Journal:  Surg Endosc       Date:  2012-03-22       Impact factor: 4.584

Review 2.  Population-based screening for colorectal cancer with faecal occult blood test--do we really have enough evidence?

Authors:  Göran Ekelund; Jonas Manjer; Sophia Zackrisson
Journal:  Int J Colorectal Dis       Date:  2010-07-30       Impact factor: 2.571

3.  The NordICC Study: rationale and design of a randomized trial on colonoscopy screening for colorectal cancer.

Authors:  M F Kaminski; M Bretthauer; A G Zauber; E J Kuipers; H-O Adami; M van Ballegooijen; J Regula; M van Leerdam; T Stefansson; L Påhlman; E Dekker; M A Hernán; K Garborg; G Hoff
Journal:  Endoscopy       Date:  2012-06-21       Impact factor: 10.093

4.  The risk of postpolypectomy bleeding during colonoscopy in patients with early liver cirrhosis.

Authors:  Jung Won Jeon; Hyun Phil Shin; Joung Il Lee; Kwang Ro Joo; Kwan Mi Pack; Jae Myung Cha; Jae Jun Park; Jun Uk Lim; Kyuseong Lim
Journal:  Surg Endosc       Date:  2012-05-31       Impact factor: 4.584

5.  Improved bowel preparation increases polyp detection and unmasks significant polyp miss rate.

Authors:  Ioannis S Papanikolaou; Athanasios D Sioulas; Nektarios Magdalinos; Iosif Beintaris; Lazaros-Dimitrios Lazaridis; Dimitrios Polymeros; Chrysoula Malli; George D Dimitriadis; Konstantinos Triantafyllou
Journal:  World J Clin Cases       Date:  2015-10-16       Impact factor: 1.337

6.  Approach to Incomplete Colonoscopy: New Techniques and Technologies.

Authors:  Diana L Franco; Jonathan A Leighton; Suryakanth R Gurudu
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-08

Review 7.  Genomic era diagnosis and management of hereditary and sporadic colon cancer.

Authors:  Edward David Esplin; Michael Paul Snyder
Journal:  World J Clin Oncol       Date:  2014-12-10

8.  Risk of Metachronous Advanced Neoplasia in Patients With Multiple Diminutive Adenomas.

Authors:  Jung Yoon Kim; Tae Jun Kim; Sun-Young Baek; Soohyun Ahn; Eun Ran Kim; Sung Noh Hong; Dong Kyung Chang; Young-Ho Kim
Journal:  Am J Gastroenterol       Date:  2018-08-03       Impact factor: 10.864

9.  Public health and cooperative group partnership: a colorectal cancer intervention.

Authors:  Sherri G Homan; Bob R Steward; Jane M Armer
Journal:  Semin Oncol Nurs       Date:  2013-12-19       Impact factor: 2.315

10.  Polyp surveillance.

Authors:  W Donald Buie; Anthony R MacLean
Journal:  Clin Colon Rectal Surg       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.